Welcome to Innovacell Biotechnologie AG
Innovacell Biotechnologie AG is an innovative biotechnology company that develops personalized cell therapies for treatment of incontinence. Innovacell is running multinational clinical trials for its two ‘tissue-engineered’ products in development, urocell® and rectocell®. Using Innovacell’s innovative ‘ultrasound-guided’ injector, patients benefit from a minimally invasive surgery. More than 500 patients have been treated since 2002.
Cures for Incontinence
News
Press release: 2010-06-09Innovacell includes first patients in study for urocell® A total of 245 patients will be treated during Phase IIb - the study will evaluate the effectiveness and determine the optimal dose for treatment. read more »